Rationale for beta-adrenergic blocking drugs in cardiomyopathy.

[1]  N. Kantrowitz,et al.  Beta-adrenergic function in heart muscle disease and heart failure. , 1985, Journal of molecular and cellular cardiology.

[2]  M. Moeschberger,et al.  Factors influencing the one-year mortality of dilated cardiomyopathy. , 1984, The American journal of cardiology.

[3]  M. Caron,et al.  Mechanisms of membrane-receptor regulation. Biochemical, physiological, and clinical insights derived from studies of the adrenergic receptors. , 1984, The New England journal of medicine.

[4]  K. Swedberg,et al.  Intravenous and oral prenalterol in congestive heart failure. Effects on systemic and coronary hemodynamics and myocardial catecholamine balance. , 1984, The American journal of medicine.

[5]  S. Vatner,et al.  Effects of pressure overload, left ventricular hypertrophy on beta-adrenergic receptors, and responsiveness to catecholamines. , 1984, The Journal of clinical investigation.

[6]  J. Federman,et al.  Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy. , 1984, Journal of the American College of Cardiology.

[7]  S. Mallov.  Role of calcium and free fatty acids in epinephrine-induced myocardial necrosis. , 1983, Toxicology and applied pharmacology.

[8]  D. Harrison,et al.  Study of the normal and failing isolated human heart: decreased response of failing heart to isoproterenol. , 1983, American heart journal.

[9]  M. Quiñones,et al.  Evaluation of metoprolol in suppressing complex ventricular arrhythmias. , 1983, The American journal of cardiology.

[10]  S. Downing,et al.  Contribution of γ‐Adrenoceptor Activation to the Pathogenesis of Norepinephrine Cardiomyopathy , 1983, Circulation research.

[11]  F. Waagstein,et al.  Beta-blockers in dilated cardiomyopathies: they work. , 1983, European heart journal.

[12]  A. M. Watanabe,et al.  Recent advances in knowledge about beta-adrenergic receptors: application to clinical cardiology. , 1983, Journal of the American College of Cardiology.

[13]  P. Molinoff,et al.  Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists. , 1983, The Journal of pharmacology and experimental therapeutics.

[14]  K. Weber,et al.  Low-dose beta blockade in the treatment of chronic cardiac failure. , 1982, American heart journal.

[15]  J. Cohn,et al.  Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure. , 1982, American heart journal.

[16]  D C Harrison,et al.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.

[17]  E. Sonnenblick,et al.  Contractile Reserve and Left Ventricular Function in Regional Myocardial Ischemia in the Dog , 1982, Circulation.

[18]  J. Willerson,et al.  Relationship between β‐Adrenergic Receptor Numbers and Physiological Responses during Experimental Canine Myocardial Ischemia , 1982, Circulation research.

[19]  N. Dhalla,et al.  Influence of reducing agents on adrenochrome-induced changes in the heart. , 1981, Archives of pathology & laboratory medicine.

[20]  H. Ikram,et al.  DOUBLE-BLIND TRIAL OF CHRONIC ORAL BETA BLOCKADE IN CONGESTIVE CARDIOMYOPATHY , 1981, The Lancet.

[21]  J. Cohn,et al.  Neurohumoral control mechanisms in congestive heart failure. , 1981, American heart journal.

[22]  N. Dhalla,et al.  Ventricular dysfunction and necrosis produced by adrenochrome metabolite of epinephrine: relation to pathogenesis of catecholamine cardiomyopathy. , 1981, American heart journal.

[23]  E. Braunwald,et al.  Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. , 1981, The New England journal of medicine.

[24]  G. Baumann,et al.  Impaired beta-adrenergic stimulation in the uninvolved ventricle post-acute myocardial infarction: reversible defect due to excessive circulating catecholamine-induced decline in number and affinity of beta-receptors. , 1981, American heart journal.

[25]  Morris J. Brown,et al.  Chronic heart failure in the guinea pig increases cardiac α1- and β-adrenoceptors , 1980 .

[26]  K. Swedberg,et al.  Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. , 1980, British heart journal.

[27]  K. Swedberg,et al.  Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy. , 1980, British heart journal.

[28]  K. Swedberg,et al.  PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADE , 1979, The Lancet.

[29]  W. Nayler,et al.  Uptake of catecholamines by human cardiac muscle in vitro. , 1979, British heart journal.

[30]  J. A. Thomas,et al.  Plasma norepinephrine in congestive heart failure. , 1978, The American journal of cardiology.

[31]  E. Braunwald.  Beta-adrenergic blockade : a new era in cardiovascular medicine , 1978 .

[32]  W. Newman.  A depressed response of left ventricular contractile force to isoproterenol and norepinephrine in dogs with congestive heart failure. , 1977, American heart journal.

[33]  E. Varnauskas,et al.  Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. , 1975, British heart journal.

[34]  D. Harrison,et al.  Effect of propranolol on left ventricular function, segmental wall motion, and diastolic pressure-volume relation in man. , 1975, British heart journal.

[35]  J. Goodwin,et al.  Prospects and Predictions for the Cardiomyopathies , 1974, Circulation.

[36]  J. Haft.  Cardiovascular injury induced by sympathetic catecholamines. , 1974, Progress in cardiovascular diseases.

[37]  O. Pachinger,et al.  Ca overload as the determinant factor in the production of catecholamine-induced myocardial lesions. , 1973, Recent advances in studies on cardiac structure and metabolism.

[38]  D. Reichenbach,et al.  Catecholamines and cardiomyopathy: The pathogenesis and potential importance of myofibrillar degeneration , 1970 .

[39]  Arthur J. Moss,et al.  Cardiovascular Effects of Sustained Norepinephrine Infusions. II. Morphology , 1966, Circulation research.

[40]  E. Braunwald,et al.  CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE. , 1965, The American journal of medicine.

[41]  E. Braunwald,et al.  MYOCARDIAL NOREPINEPHRINE CONCENTRATION IN MAN. EFFECTS OF RESERPINE AND OF CONGESTIVE HEART FAILURE. , 1963, The New England journal of medicine.

[42]  E. Braunwald,et al.  Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failure. , 1963, The American journal of medicine.

[43]  M. Gerová,et al.  The role of parameters of pulsating pressure in the stimulation of intracarotid receptors. , 1962, Archives internationales de pharmacodynamie et de therapie.

[44]  E. Braunwald,et al.  Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure. , 1962, The New England journal of medicine.

[45]  G. Rona,et al.  An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. , 1959, A.M.A. archives of pathology.

[46]  R. M. Pearce.  EXPERIMENTAL MYOCARDITIS; A STUDY OF THE HISTOLOGICAL CHANGES FOLLOWING INTRAVENOUS INJECTIONS OF ADRENALIN , 1904, The Journal of experimental medicine.